截断的迷你LRP1将货物从光线侧向基侧侧通过血脑屏障运输
Laura Fritzen1, Katharina Wienken2, Lelia Wagner2
1Molecular Neurodegeneration, Institute for Pathobiochemistry, University Medical Center of the Johannes Gutenberg-University of Mainz, Duesbergweg 6, 55099, Mainz, Germany. fritzenl@uni-mainz.de.
Fluids and barriers of the CNS
|September 17, 2024
概括
这项研究引入了微型低密度脂蛋白受体相关蛋白1 (mLRP1_DIV*) 作为一种新型载体,用于通过血脑屏障 (BBB) 传递药物. mLRP1_DIV* 促进运输和治疗性货物释放到中枢神经系统.
科学领域:
- 神经科学是一个神经科学.
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
背景情况:
- 血脑屏障 (BBB) 对中枢神经系统 (CNS) 药物输送构成重大挑战.
- 之前的研究使用纳米颗粒配方来准中枢神经系统治疗药物的BBB受体.
- 对于中枢神经系统的进入和辅酶体运动的明确机制仍然难以捉摸.
研究的目的:
- 为了研究截断的迷你低密度脂蛋白受体相关蛋白1 (mLRP1_DIV*) 作为血液到大脑的运输载体.
- 举个例子,mLRP1_DIV*使用抗体和免疫聚体用于中枢神经系统的药物输送.
- 在体外 (in vitro) 系统选受体及其连接体在内皮细胞的运输路径.
主要方法:
- 在体外BBB模型 (hcMEC/D3和bEnd.3细胞) 中使用内部化和运输试验验验证mLRP1_DIV*作为脂质体载体.
- 通过免疫光学分析mLRP1_DIV*和通过内皮细胞的货物贩运路线.
- 在共同培养中研究携带BB25的免疫聚体对γ-分泌酶活性调节的研究.
主要成果:
- 在BBB模型中,mLRP1_DIV*在体外证明了抗体和功能化的免疫脂质体的运输.
- 观察到货物释放是mLRP1_DIV*-依赖的.
- 携带gamma分泌酶调节器BB25的脂质体在运输后有效降低了有毒的Aß42水平.
结论:
- mLRP1_DIV*作为一种用于中枢神经系统药物输送的工具显示出希望.
- 它可以通过内皮单层直接运输货物,并释放到大脑外围细胞.
- 交付的货物在体外表现出其预期的治疗效果.
相关概念视频
00:49The Blood-brain Barrier
47.0K
Overview
47.0K
01:20Cotranslational Protein Translocation
7.2K
Translocation of proteins across membranes is an ancient process that occurs even in bacteria and archaebacteria. In fact, the components of the translocation machinery are still conserved between prokaryotes and eukaryotes.
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
7.2K
01:39Receptor-mediated Endocytosis
104.1K
Overview
104.1K
01:06Carrier-Mediated Transport
310
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
310
01:45ER Retrieval Pathway
3.8K
In the secretory pathway, vesicles transport proteins from one cellular compartment to another in forward transport to deliver the protein to its correct location. Occasionally, misfolded proteins and incorrect proteins escape their original compartments, and a retrieval pathway is used to return the escaped proteins to their original compartment.
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
3.8K
01:45Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K